These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36431254)

  • 1. A Retrospective Assessment of Laboratory Findings and Cytokine Markers in Severe SARS-CoV-2 Infection among Patients of Roma Population.
    Mocanu A; Lazureanu VE; Marinescu AR; Cut TG; Laza R; Rusu LC; Marza AM; Nelson-Twakor A; Negrean RA; Popescu IM; Mederle AO
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory Findings and Clinical Outcomes of ICU-admitted COVID-19 Patients: A Retrospective Assessment of Particularities Identified among Romanian Minorities.
    Mocanu A; Lazureanu VE; Laza R; Marinescu AR; Cut TG; Sincaru SV; Marza AM; Popescu IM; Herlo LF; Nelson-Twakor A; Rivis M; Bratosinand F; Porosnicu TM; Mederle AO
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
    Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers.
    Geetha HS; Singh G; Sekar A; Gogtay M; Singh Y; Abraham GM; Trivedi N
    World J Clin Cases; 2023 Feb; 11(6):1287-1298. PubMed ID: 36926123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission Dynamics of SARS-CoV-2 during an Outbreak in a Roma Community in Thessaly, Greece-Control Measures and Lessons Learned.
    Koureas M; Speletas M; Bogogiannidou Z; Babalis D; Pinakas V; Pinaka O; Komnos A; Tsoutsa S; Papadamou G; Kyritsi MA; Vontas A; Nakoulas V; Sapounas S; Kanellopoulos N; Kalompatsios D; Papadouli V; Dadouli K; Soteriades S; Mina P; Mouchtouri VA; Anagnostopoulos L; Stamoulis KE; Agorastos K; Petinaki EA; Prezerakos P; Tsiodras S; Hadjichristodoulou C
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity.
    Dai CL; Kornilov SA; Roper RT; Cohen-Cline H; Jade K; Smith B; Heath JR; Diaz G; Goldman JD; Magis AT; Hadlock JJ
    Clin Infect Dis; 2021 Dec; 73(12):2193-2204. PubMed ID: 33608710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Mathur R; Rentsch CT; Morton CE; Hulme WJ; Schultze A; MacKenna B; Eggo RM; Bhaskaran K; Wong AYS; Williamson EJ; Forbes H; Wing K; McDonald HI; Bates C; Bacon S; Walker AJ; Evans D; Inglesby P; Mehrkar A; Curtis HJ; DeVito NJ; Croker R; Drysdale H; Cockburn J; Parry J; Hester F; Harper S; Douglas IJ; Tomlinson L; Evans SJW; Grieve R; Harrison D; Rowan K; Khunti K; Chaturvedi N; Smeeth L; Goldacre B;
    Lancet; 2021 May; 397(10286):1711-1724. PubMed ID: 33939953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic variables as predictors of adverse outcome in SARS-CoV-2 infection: an Irish hospital experience.
    Farrell RJ; O'Regan R; O'Neill E; Bowens G; Maclellan A; Gileece A; Bradley M; Smyth C; Kelly O; Hall B; Cormican L; Faul J; Wanic K; McDermott J; Sreenan S; Tun TK; Duffy T; Bhatti AI; Donohoe O; Leen E; Collins N; McGeary S; Cody C; Dolan E; Burke C
    Ir J Med Sci; 2021 Aug; 190(3):893-903. PubMed ID: 33141353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community-health partnership response to mitigate the impact of the COVID-19 pandemic on Travellers and Roma in Ireland.
    Villani J; Daly P; Fay R; Kavanagh L; McDonagh S; Amin N
    Glob Health Promot; 2021 Jun; 28(2):46-55. PubMed ID: 33657936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.